Micro (mi)RNAs are small, evolutionarily conserved and endogenous noncoding RNA molecules between 19 and 24 nucleotides in length. The potential roles of miRNAs in the carcinogenesis and progression of non-small cell lung cancer (NSCLC) have been studied previously. In the present study, it was revealed that miRNA-216b (miR-216b) expression was lower in NSCLC tissue and cell lines compared with that in adjacent healthy lung tissue samples and the normal bronchial epithelial 16HBE cell line, respectively. The ectopic expression of miR-216b inhibited the proliferation and invasion of NSCLC cells in vitro. SRY-Box 9 (SOX9) was identified as a direct target of miR-216b in NSCLC. In addition, SOX9 small interfering RNA was able to mimic the effects of miR-216b overexpression on cell proliferation and invasion in NSCLC. Therefore, the data reported in the present study demonstrate that miR-216b is an important tumor suppressor in NSCLC. These data may contribute to the understanding of the molecular mechanism underlying the carcinogenesis and progression of NSCLC, and provide novel therapies for patients with NSCLC.
[1]Shanghai Jiao Tong Univ, Sch Med, XinHua Hosp, Dept Thorac Surg, Shanghai 200092, Peoples R China.
[2]Jilin Univ, Hosp 1, Dept Geriatr, 71 XinMin St, Changchun 130021, Jilin, Peoples R China.
[3]Changchun Univ Chinese Med, Affiliated Hosp, Dept Tumor & Blood Dis, Changchun 130021, Jilin, Peoples R China.
[4]Peoples Hosp Jilin Prov, Dept Infect, Changchun 130021, Jilin, Peoples R China.
(8.0+极速模式)